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Abstract
Background: Retinal degenerations, such as age-related macular degeneration (AMD) and retinitis pigmentosa (RP),
are characterized by photoreceptor loss and anomalous remodeling of the surviving retina that corrupts visual
processing and poses a barrier to late-stage therapeutic interventions in particular. However, the molecular events
associated with retinal remodeling remain largely unknown. Given our prior evidence of ionotropic glutamate
receptor (iGluR) reprogramming in retinal degenerations, we hypothesized that the edited glutamate receptor 2
(GluR2) subunit and its trafficking may be modulated in retinal degenerations.
Results: Adult albino Balb/C mice were exposed to intense light for 24 h to induce light-induced retinal
degeneration (LIRD). We found that prior to the onset of photoreceptor loss, protein levels of GluR2 and related
trafficking proteins, including glutamate receptor-interacting protein 1 (GRIP1) and postsynaptic density protein 95
(PSD-95), were rapidly increased. LIRD triggered neuritogenesis in photoreceptor survival regions, where GluR2 and
its trafficking proteins were expressed in the anomalous dendrites. Immunoprecipitation analysis showed
interaction between KIF3A and GRIP1 as well as PSD-95, suggesting that KIF3A may mediate transport of GluR2
and its trafficking proteins to the novel dendrites. However, in areas of photoreceptor loss, GluR2 along with its
trafficking proteins nearly vanished in retracted retinal neurites.
Conclusions: All together, LIRD rapidly triggers GluR2 plasticity, which is a potential mechanism behind
functionally phenotypic revisions of retinal neurons and neuritogenesis during retinal degenerations.
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Background
Retinal degenerations (RD), such as age-related macular
degeneration (AMD) and retinitis pigmentosa (RP), are
progressive disorders initiated by photoreceptor stress and
are accelerated by photoreceptor death, which effectively
deafferents the inner retina and evolves into formal retinal
remodeling [1-3]. Thus, retinal remodeling proceeds
through three phases: 1, photoreceptor stress; 2, photore-
ceptor death and 3, complex neural remodeling [3]. Two
of the major hallmarks of retinal remodeling are growth of
novel neurites and functional reprogramming of existing
retinal neurons [1-8]. Pathogenic neuronal reprogramming
and de novo neuritogenesis are not isolated to retinal tis-
sues, as pathological revision also occurs in neurodegen-
erative diseases such as epilepsy [9] and Alzheimer’s
disease [10]. Retinal remodeling limits the effectiveness of
vision rescue strategies including photoreceptor- and ret-
inal pigment epithelium (RPE)-directed therapies
[4,6,7,11,12]. Better understanding of the mechanisms
underlying retinal remodeling will improve the outcomes
of genetic, molecular, cellular and bionic rescues.
Deafferentation of the neural retina eliminates the
intrinsic glutamatergic drive by the sensory retina [3]
and induces glutamate receptor reprogramming before
gross topologic restructuring of the retina begins [4,13].
In phase 2 degenerating retinas with extensive rod
death, the downstream rod-specific signaling pathways
persists [13,14], and bipolar cells still respond to gluta-
mate receptor agonists [4,7,15]. Among the glutamate
receptors (GluRs), a-amino-3-hydroxy-5-methyl-4-isoxa-
zolepropionic acid (AMPA) receptors mediate fast
synaptic transmission at excitatory synapses in CNS and
are tetrameric assemblies of subunits GluR1-4 encoded
by separate genes [16]. Their involvement and
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ticity and structural remodeling is fundamental to tim-
ing and coherence of developing neural networks [17].
In brain, combined neuronal activity and pathologic
insults trigger rapid changes in postsynaptic AMPA
receptor attributes (e.g. subunit composition) and may
control Ca
2+ permeability [18]. Ca
2+ fluxes play critical
roles in neural function, including the regulation of
neurite outgrowth and synaptogenesis [19], synaptic
transmission and plasticity [20], and cell survival [21].
GluR2 in heteromeric AMPARs renders the channel low
permeable to Ca
2+ [22,23], so that even a modest altera-
tion in the level of GluR2 is expected to have profound
implications for synaptic efficacy and neuronal survival
[24].
Given prior evidence of iGluR reprogramming in human
RP and animal models of RD [4,8,25], we hypothesized
that retinal iGluRs, especially GluR2 subunits are modu-
lated in retinal degenerative diseases. GluR2 subunit
expression is associated with vertical channel retinal pro-
cessing [26-28], and its expression limits AMPAR perme-
ability to Ca
2+ [29]. In this sense it is thought to be
neuroprotective [30,31]. To study the kinetics of GluR2
expression and trafficking in retinal degenerative disease,
we used the LIRD model, which contains the full spectrum
of sequelae found in naturally occurring and engineered
forms of retinal degeneration and remodeling, including
early retinal stress, photoreceptor loss, Müller cell remo-
deling, neuritogenesis [8], and remodeling of all neural cell
populations in the retina and formation of microneuromas
[8,12]. Our analysis of glutamate receptors and neurito-
genesis in the light-damage model spans phases 1 and 2.
This work demonstrated that in a LIRD model, GluR2
levels and trafficking rapidly increased in response to
light-induced photoreceptor stress and death, providing a
potential feedback mechanism for controlling Ca
2+ perme-
ability in retinal neurons. Most importantly, GluR2 upre-
gulation may occur in ON bipolar cells, which are
normally hyperpolarized by glutamate. Expression of
AMPA receptors would change their polarity as predicted
by Marc et al 2007 [4] and Jones et al. [13] in mouse, rab-
bit and human retina. In addition, the motor protein
KIF3A colocalized well with PSD-95 and GRIP1 at novel
sprouting neurites, potentially indicating a chaperone role
for KIF3A, guiding GluR2 and its trafficking proteins to
newly forming dendritic processes.
Results
LIRD increases GluR2 expression prior to obvious
photoreceptor loss
LIRD led to dramatic photoreceptors loss by post-light
exposure day 7 (pLX7) (Figure 1A), demonstrating that
LIRD is a “fast degenerating” animal model of retinal
degeneration [32]. Consistent with our previous results
[8,12], light stress differentiated the mouse retina into
survivor zones, where stressed photoreceptors and ret-
inal neurons persisted, and light-damage zones, where
rods and cones died (Figure 1B). Despite that DAPI
staining showed a normal thickness of inner nuclear
layer (INL) in both the survivor and light-damage zones
and histological analysis of retina revealed normal lami-
nation and topology at light onset (pLX0) through pLX1
(Figure 1A and 1B), protein levels of GluR2 showed
immediate response to light stress. Specifically, protein
levels of GluR2 increased immediately at pLX0, peaked
at pLX7, and recovered to almost control levels by
pLX30 (Figure 1C and 1D). GluR2 immunostaining of
control tissues (postnatal day 80) revealed GluR2-immu-
noreactive puncta aggregating in the outer plexiform
layer (OPL) with more GluR2-immunoreactive puncta
found throughout the OFF and ON sublamina (Figure
1E).
GluR2 trafficking protein levels are modulated during
LIRD
GluR2 is assembled, with other GluR subunits, into
iGluR channels in the postsynaptic membrane [33]. The
C-terminus of GluR2 contains a PDZ domain that binds
GluR2 to trafficking proteins including GRIP1, ABP,
PICK1 [34-36], and stargazin [37]. GluR2 is anchored at
synaptic and intracellular membranes by ABP/GRIP but
cycles between these membranes in association with
PICK1 [38]. Consistent with a previous report [39],
PSD-95 was most prominent in the rod spherules and
cone pedicles of the OPL, weak PSD-95 labeling was
also present in the inner plexiform layer (IPL) (Figure
2A). The retinal distributions of GluR2 trafficking pro-
teins GRIP1, ABP, PICK1 and stargazin showed labeling
in the OPL and IPL (Figure 2B-E). These data confirm
the presence of GluR2-related PSD proteins such as
ABP and GRIP1 in the retina as demonstrated by Gab-
riel et al [40]. Similar to findings in GluR2 protein
expression, PSD-95, GRIP1, ABP, and stargazin expres-
sion were increased by light stress, levels of PSD-95,
ABP, and GRIP1 peaked at pLX1 and then recovered,
while the levels of stargazin were elevated from pLX1 to
pLX30, the last time point in the experiment (Figure 2F
and 2G). Protein levels of PKCa and PICK1 were unal-
tered by light exposure from pLX1 to pLX30 (Figure 2F
and 2G). Western blotting images of PSD-95 protein
levels revealed three adjacent bands (Figure 2F), poten-
tially due to that the anti-PSD-95 IgG targets a common
epitope in the homologous regions [39].
LIRD triggers neuritogenesis by rod bipolar cells and
horizontal cells in the survivor zone
In control retinas, PKCa staining revealed fine, bushy
dendritic processes of rod bipolar cells only in the OPL
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exhibited dramatic neuritogenesis occurring by pLX7 in
the survivor zone (data not shown) and becoming more
obvious by pLX30. Rod bipolar cells in the LIRD retinas
extended their dendrites from the OPL into outer
nuclear layer (ONL) (Figure 3B and 3B’, highlighted by
arrows) in the survivor zone. Further, calbindin immu-
nostaining revealed calbindin-positive horizontal cells
undergoing similar neuritogenesis. While neurites of
horizontal cells were confined in the OPL in the control
retina (Figure 3C), horizontal cells in the LIRD retinas
extended their neurites from the OPL into the ONL in
t h es u r v i v o rz o n e( F i g u r e3 Da n d3 D ’,h i g h l i g h t e db y
arrows). These findings are consitent with the formation
of novel neurites found in human RP, AMD and animal
models of retinal degenerations [5,6,13,41-43].
GluR2 and its trafficking proteins are expressed in the
new neurites in the survivor zone
We correlated the findings of neuritogenesis here with
alterations in GluR2 trafficking. Examination of expres-
sion patterns of GluR2 and its trafficking proteins in
new neurites demonstrated that GluR2, PSD-95, starga-
zin, PICK1, GRIP1 and ABP were present in the OPL as
well as in the ONL during LIRD (Figure 4A-F). GluR2
partially co-localized with PKCa in the new neurites
Figure 1 Light stress induced photoreceptor degeneration and increased GluR2 levels. A, B.D A P Is t a i n i n gs h o w e dt h a tl i g h ts t r e s s
dramatically led to photoreceptor loss by pLX7. The whole retina thus was differentiated into light-damage and survivor zones. Western blotting
(C) and analysis (D) showed increased levels of GluR2, n = 9. E. Confocal imaging revealed expected GluR2 expression in the OPL and IPL of
control retina (postnatal day 80); scale = 20 μm.
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new neurites of rod bipolar cells during retinal degen-
erations. Different from PKCa, PSD-95 co-localized well
with GluR2 in the new neurites in the ONL (Figure 4B).
GluR2 also co-localized well with PICK1 (Figure 4C),
GRIP1 (Figure 4D), stargazin (Figure 4E), and ABP (Fig-
ure 4F) in the new neurites in the ONL. These data are
consistent with the data proposing PSD-95, stargazin,
PICK1, GRIP1 and ABP as anchoring of GluR2 at
synaptic locations [44].
KIF3A interacts with GRIP1 and PSD-95 in mouse retina
KIF3A is a reported motor protein expressed at the
basal body of the connecting cilium axoneme and at the
synaptic ribbons of cones and rods [45]. Our data
showed that KIF3A was expressed in the OPL and IPL
of control retina (Figure 5A), thereby raising the possibi-
lity that KIF3A interacts with postsynaptic density
proteins which are also present in the OPL and IPL.
Protein expression of KIF3A during LIRD was relatively
stable, with a slight decrease on pLX7 (Figure 5B). Inter-
actions between KIF3A and GRIP1 and PSD-95 were
demonstrated by immunoprecipitation analysis (Figure
5C). During LIRD, KIF3A was also expressed in the new
neurites, where KIF3A co-localized well with PSD-95
(Figure 5D) and GRIP1 (Figure 5E), suggesting that
KIF3A may be involved in guiding GluR2 and its traf-
ficking protein to the new dendrites.
GluR2 and its trafficking proteins are lost in the light-
damage zone
In contrast to the survivor zone, GluR2 expression dis-
appeared by pLX30 in the light-damage zone, where
only one layer of photoreceptors was left (Figure 6A).
The expression of PSD-95 was also dramatically
decreased in the light-damage zone (Figure 6B). Similar
Figure 2 GluR2 trafficking proteins were modulated during LIRD. Confocal imaging showed that PSD-95 (A), ABP (B), PICK1 (C), GRIP1 (D),
and stargazin (E) were expressed in the OPL and IPL (postnatal day 80). Western blotting (F) and analysis (G) showed that protein levels of PSD-
95, ABP, GRIP1, and stargazin were increased, while levels of PICK1 and PKCa showed no change, n = 9; scale = 20 μm.
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and stargazin disappeared in the light-damage zone
(data not shown). In parallel with the loss of GluR2 and
its trafficking proteins, dendrites of rod bipolar cells and
neurites of horizontal cells in the light-damage zone
OPL were retracted and flattened (Figure 6C and 6D).
We also observed a horizontal cell body located adjacent
to the RPE at the distal border of the remnant ONL
(Figure 6D, arrow).
Protein levels of calcium-buffering proteins show no
change during LIRD
The major subunits of AMPA receptors, GluR1 and
GluR2, play have important roles in neuroplasticity [44].
Figure 3 LIRD induced retinal neuritogenesis. A, B.P K C a immunohistochemistry revealed that LIRD induced neuritogenesis by rod bipolar
cells, with dendrites extending from the OPL into the ONL (highlighted by arrows). C, D. Calbindin immunohistochemistry showed
neuritogenesis by horizontal cells with processes extending from the OPL into the ONL in the survivor zone (highlighted by arrows). B’ and D’
are high magnification views of the rectangular areas in B and D, scale = 15 μm( A-D)o r6μm( B’, D’).
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examined the effect of LIRD on GluR1. Phosphorylation
of GluR1 is a major mechanism for controlling excita-
tion. Since our light damage protocol spans the period
of photoreceptor stress (increased extracellular gluta-
mate) all the way to complete photoreceptor loss, we
deemed it appropriate to screen events known in CNS
to modulate excitation. Further, GluR2 binds to PICK1
after phosphorylation at serine 880 by PKCa,w h i c h
induces dissociation of GluR2 from GRIP and the subse-
quent internalization of GluR2 by PICK1 for recycling
or degradation [38]. Thus, we also measured the levels
of phosphorylated GluR1 (Ser831) (pGluR1) and phos-
phorylated GluR2 (Ser880) (pGluR2). Our results
revealed that light stress had no significant effect on the
protein levels of GluR1 (Figure 7A and 7B). However,
light stress rapidly decreased the levels of pGluR1,
which showed an obvious decrease on pLX0 and
reached a minimum on pLX7 but recovered by pLX30.
Light stress also decreased the expression of pGluR2 by
pLX0, extending its decrease by pLX30. Two calcium
binding proteins, calretinin and calbindin, were also
examined but showed no LIRD-induced change in pro-
tein expression (Figure 7A and 7B).
Effect of AMPA receptors antagonist NBQX on
neuritogenesis during LIRD
Ca
2+/calmodulin-dependent protein kinase II (CaMKII)
senses cytosolic Ca
2+ fluxes, which are largely mediated
by glutamate-activated AMPA or NMDA receptors in
CNS neurons [46]. CaMKII plays a central role in
synaptic plasticity, both a-a n db-CaMKII are neuron-
specific and expressed in retinal neurons [47]. aCaMKII
is activated by high Ca
2+ levels, while bCaMKII is more
sensitive to lower Ca
2+ levels, and heteromeric CaMKII
Ca
2+ responsivity and activity depends on the a/b
Figure 4 GluR2 and its trafficking proteins were expressed in the new neurites in the survivor zone ONL. A. GluR2 partially co-localized
PKCa in the new neurites. Long tail arrows indicate colocalization of GluR2 and PKCa, while short tail arrows indicate non colocalization of
GluR2 and PKCa in the new dendrites. B. GluR2 co-localized with PSD-95. C. GluR2 co-localized with PICK1. D. GluR2 co-localized with GRIP1. E.
GluR2 co-localized with stargazin, and (F) GluR2 co-localized with ABP in the new neurites; scale = 3 μm.
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decrease the CaMKII a/b ratio, likely by upregulating
transcription of bCaMKII [49], which positively corre-
lates with the increase in low calcium permeability
GluR2 expression in our study. Our previous study
revealed that CaMKII plays an important role in neuri-
togenesis during retinal degeneration [8]. Therefore, we
studied the effects of AMPA receptors antagonist
NBQX on CaMKII signaling and neuritogenesis. Our
results showed that NBQX slightly mitigated neurito-
genesis. Consistently, NBQX had no effect on the ratio
of a/bCaMKII compared with vehicle group during
LIRD (Figure 8A, B, and 8D-F). However, NMDA recep-
tors antagonist D-AP5 obviously increased the ratio of
a/bCaMKII and significantly accelerated neuritogenesis
(Figure 8A, C and 8D-F). Because NBQX is neuropro-
tective [50] but does not block downregulation of GluR2
[51], our results suggest that NBQX affords neuropro-
tection by a direct block of GluR2-lacking, Ca
2+-perme-
able AMPA receptors [31]. Due to that GluR1 levels
were not altered during LIRD, the above results totally
suggest that AMPA receptor GluR2 in particular drives
Figure 5 KIF3A interacted with GRIP1 and PSD-95 in mouse retina. A. KIF3A staining showed that KIF3A was expressed in the OPL and IPL
(postnatal day 80). B. Western blotting analysis showed that LIRD had no obvious effect on the protein levels of KIF3A. C. Immunoprecipitation
analysis showed direct interaction between KIF3A and PSD-95, GRIP1. D. E. Confocal imaging showed that KIF3A co-localized well with PSD-95
(D) and GRIP1 (E) in the new neurites in the ONL; scale = 15 μm( A)o r3μm( D, E).
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LIRD.
Discussion
We reveal a correlation of neurite formation and retrac-
tion with changes in expression of GluR2 and GluR2
trafficking machinery in the LIRD model. Alterations in
GluR2 expression may provide a feedback mechanism
for altering Ca
2+ permeability in deafferented retinal
neurons, therefore be responsible for de novo neurito-
genesis, and ultimately contribute to functional repro-
gramming of neural circuitry.
Normally, increasing the ratio of GluR2 subunits in
iGluRs plays a protective role by decreasing Ca
2+
loads in neurons, which likely can not be blocked by
AMPA receptors inhibitor NBQX [31]. Additionally,
GluR2-mediated decreases in Ca
2+ permeability can
prevent GluR1 phosphorylation-dependent increases
in calcium conductance [52]. In LIRD, GluR1 expres-
sion is not changed while GluR1 phosphorylation
decreases and levels of calcium-buffering proteins cal-
retinin and calbindin remain stable. Similarly, data
from diabetic subjects showed significant retinal
increases of GluR2 but not GluR1 immunoreactivity
in the OPL and IPL [53-55]. GluR2 upregulation in
various retinal disease models suggests that this may
be a protective response to photoreceptor-mediated
stress and deafferentation.
Figure 6 GluR2 expression was lost in the light-damage zone. Expression of GluR2 (A) and its trafficking proteins such as PSD-95 (B)w e r e
dramatically decreased in the OPL of the light-damage zone (pLX30). PKCa (C) and calbindin (D) staining showed that rod bipolar cells
dendrites and horizontal cells neurites were truncated in the OPL the light-damage zone (pLX30); scale = 20 μm.
Figure 7 Effect of LIRD on the protein expression of calcium-buffering proteins. Western blotting (A)a n da n a l y s i s( B) showed that LIRD
had no effect on the levels of GluR1, calretinin and calbindin, but decreased the levels of pGluR1 and pGluR2, n = 9.
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neuritogenesis. Compared with control (vehicle) (A), sub-retinal injection of NBQX (B) had no effect on neuritogenesis while D-AP5 (C)
accelerated neuritogenesis. D. Summary data (mean ± s.e.m.) for the length of rod bipolar cell dendrites, *P < 0.05 vs control (vehicle), n = 5. E,
F. Western blot (E) and analysis (F) showed the levels of aCaMKII and bCaMKII after sub-retinal injection of NBQX and D-AP5 (pLX1).
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unchanged in rd mouse retina [56]. Most inherited
degenerations are slow compared to light damage and
their time profiles are complex [1,2]. Even the fast rd
model requires 3 months for all photoreceptors to die
and there is no known coherent stress period (at least
we don’t know if anyone has published such an analy-
sis). Light damage has a very precise onset of a few
hours. The 1995 Duvoison paper [56] does not specify
the time point at which the 35S GluR ISH autoradio-
graphic measurements were made. As shown by Jones
et al. [13,57], Marc et al. [1,2,4,12], RD (including light
damage) have complex time profiles and pass through
three distinct phases: phase 1 (photoreceptor stress and
early death), phase 2 (active photoreceptor death), phase
3 (remodeling after all photoreceptors are lost). Our
examination of that paper suggests that the rd animals
were adult, in which case they were in late phase 3
remodeling and the outer retina was completely deci-
mated, lacking bipolar cell and horizontal cell dendrites.
The purpose of our current paper was to profile the
kinetics of glutamate receptors before such a pathologic
state. Indeed our results show that the major changes in
GluR expression occur acutely during phase 1 of light
damage and quickly normalize, suggesting that GluR2
modulation is acute.
GluR2-mediated changes in Ca
2+ permeability may be
also responsible for the subsequent neurite outgrowth of
retinal neurons. In embryonic chick retinal neurons, early
activation of Ca
2+-permeable AMPA receptors reduces
neurite outgrowth [58], and influx of Ca
2+ through these
channels could be responsible for the reduction in neur-
ite outgrowth of cultured hippocampal pyramidal cells
[59]. GluR2 co-localizing with its trafficking proteins
PICK1, ABP, GRIP1 and stargazin at new neurites during
LIRD suggests that this same mechanism may be repre-
sented in deafferented retina. The interaction of stargazin
with AMPA receptors is essential for delivering func-
tional receptors to the surface membrane, whereas bind-
ing with PSD-95, a GluR-clustering molecule, is required
for targeting the AMPA receptors to synapses [60]. Dur-
ing GluR2 trafficking, the PICK1-ABP/GRIP interaction
targets PICK1-PKCa complexes to ABP/GRIP-AMPA
receptor complexes. GluR2 binds to PICK1 after phos-
phorylation at serine 880 by PKCa, which induces disso-
ciation of GluR2 from GRIP and the subsequent
internalization of GluR2 by PICK1 for recycling or degra-
dation [38]. Therefore, rapid alterations in GluR2 and its
trafficking during early LIRD may reveal mechanisms to
limit Ca
2+-mediated damage or simply reflect loss of den-
dritic iGluRs as dendrites are lost [4,13]. Normalization
of GluR2 expression by pLX30 may reveal new GluR2
expression in novel dendrites that are in the process of
forming new synaptic complexes.
This study demonstrates that expression of GluR2 and
its trafficking proteins in the new dendrites may be
guided through KIF3A, a member of the heteromeric
family of kinesins which constitute a large family of
microtubule motor proteins [45]. In neurons, kinesin
motors conduct transport to axons and neurotransmitter
receptors to dendrites and GRIP1 directly interacts with
kinesin enabling transport of dendritic proteins such as
GluR2 [61]. Our work reveals the expression of KIF3A in
the OPL, where is dominated by ribbon synapses between
presynaptic photoreceptors and postsynaptic horizontal
cells and bipolar cells, both of which are involved in early
reactive neuritogenesis in the degenerative retina. Inter-
action between KIF3A and GRIP1 and PSD-95 indicates
that KIF3A has the potential to steer GRIP1 and PSD-95
to the new dendritic formation. Because GluR2 and its
trafficking proteins are anchored with PSD-95, it is possi-
ble that GluR2 and its trafficking proteins are guided
indirectly by PSD-95 and GRIP1 to the new processes.
In normal tissues, differential expression of GluRs by
bipolar cells creates parallel ON and OFF channels in
vision. ON bipolar cells express mGluR6 receptors while
OFF bipolar cells express either AMPA or KA receptors.
In retinal degenerative diseases, the observation of
GluR2 in pathological newly-formed bipolar cell den-
drites is a new finding and likely contributes to the
functional reprogramming observed in bipolar cells of
degenerative retina [4,13]. Altered differential expression
of GluRs by bipolar cells explains the phenotypic revi-
sion and reprogramming of bipolar cells observed in RD
[7,12,13]. Previously, we demonstrated phenotypic plasti-
city in human RP and in animal models of cone-sparing
RP where loss of rods, but not cones, leads to phenotype
revision, inducing a switch from ON to OFF phenotypes
in rod bipolar cells [4]. Nevertheless, primate ON bipo-
lar cells also express a cohort of AMPA receptor genes
in normal retina [62] and GluR2 subunits have long
been identified in rod bipolar cells [21,26,28,55,63]. The
fact that normal rod bipolar cells express iGluR subunits
argues that such switching may be within the normal
capacity of bipolar cells [4].
Conclusions
In summary, this work is the first to study GluR2 and its
trafficking proteins during RD. Our findings suggest that
rapid alteration of GluR2 trafficking/regulation is
involved in pathological neuritogenesis and is a potential
mechanism behind phenotypic reprogramming of retinal
neurons. Modulation of GluR2 expression and its traf-
ficking may slow down primary neurite remodeling or
limit neuritogenesis. However, further research is
needed to separate the GluR2-mediated pathways that
contribute to neuroprotection and pathological
neuritogenesis.
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Animals
Age-matched female Balb/C albino mice (The Jackson
Laboratory, Bar Harbor, ME) were maintained in dim
light (20-40 lux) on a 12-12 cycle in normal phase
(lights on 7:00-19:00) with ad libitum access to food and
water. All experimental procedures were designed to
minimize animal number and suffering, and were con-
ducted with approval of the Institutional Animal Care
Committees at the University of Utah in accordance
with the ARVO Statement for the Use of Animals in
Ophthalmic and Vision Research.
LIRD and subretinal injections
LIRD and subretinal injections were performed as
described previously [8]. In brief, mice were placed into
the light-damage chamber, where the visible light inten-
sity ranged from 2,500 to 3,000 lux, for 24 h by exclud-
ing one normal night cycle. Following post-light
exposure (pLX), all animals were returned to the dim
cyclic light environment and maintained for 0, 1, 7, and
30 days (pLX0, pLX1, pLX7, and pLX30). Under keta-
mine-xylazine anesthesia, 5 μM NBQX (Sigma, St.
Louis, MO, USA) and 50 μM D-AP5 (Sigma) were
injected into the sub-retinal space (central region) of
albino mice in 0.5 μl volumes using a 33-gauge micro
syringe (Hamilton) 30 min before light exposure. A suc-
cessful sub-retinal injection caused swelling of the
retina. Control retinas were injected with vehicle
(DMSO) (Sigma).
Sample processing
At the end of the experiment, eyes were rapidly harvested
following decapitation under isoflurane anesthesia. For
Western blotting analysis, retinas were dissected in
Hank’s balanced salt solution (HBSS, GIBCO, Carlsbad,
CA, USA), then placed on ice in 1.5 ml tubes with RIPA
buffer (RIPA lysis buffer kit, Santa Cruz, CA, USA) and
homogenized using a sonicator (Fisher Scientific, Pitts-
burgh, PA, USA) three times for 12 sec each with 12 sec
breaks between cycles. The samples were put on ice for
10 min, then centrifuged at 14,000 rpm at 4°C for 10
min. Supernatants were transferred to new tubes. The
concentrations of protein in the samples were measured
using the BCA assay (Pierce, Rockford, IL USA). For
immunohistochemical analysis, whole eyes were removed
and rinsed in HBSS, fixed in 4% paraformaldehyde (PFA)
(Sigma) for 2 h at 4°C, and then washed with PBS (in g/L:
NaCl 8, KCl 0.2, Na2HPO4 1.44, KH2PO4 0.24; pH 7.4)
twice for 10 min each. Eyes were incubated in PBS with
20% sucrose for 4 h at 4°C. Serial 12 μm coronal sections
were made with a cryostat microtome (Leica CM3050 S,
Wetzlar, Germany) and collected on Superfrost/plus
microscope slides (Fisher Scientific).
Immunoprecipitation
Retinas were lysed in RIPA buffer (RIPA lysis buffer kit,
Santa Cruz) for 1 h at 4°C with gentle agitation. Lysates
were immunoprecipitated for 1 h at 4°C using KIF3A
antibody (1:1000) and then protein G agarose beads
(Roche, Indianapolis, IN, USA) [8]. Samples were ana-
lyzed by Western blotting.
Western blotting analysis
Samples of entire group were pooled. Protein samples
(~20 μg protein) were combined with NuPAGE LDS
sample buffer (4×) (Invitrogen, Carlsbad, CA, USA) and
NuPAGE sample reducing agent (10×) (Invitrogen), then
boiled for 10 min at 95°C. Western blotting analysis was
carried out using NuPAGE 4-12% Bis-Tris gels (Invitro-
gen) at 200 V for 40 min. Gels were electro-blotted
onto PVDF membrane (Millipore, Bedford, MA, USA)
for 1 h at 25 V using a wet electro-blotting system
(XCell SureLock Mini-Cell, Invitrogen). Blots were
blocked for 1 h in PBS with 0.1% Triton-x100, pH 7.4
(PBST) containing 5% non-fat dry milk (NFDM). Blots
then were incubated overnight at 4°C in primary antibo-
dies diluted in 5% NFDM-PBST solution (GluR2,
1:1000, Chemicon; pGluR2, 1:1000, Millipore; protein
kinase C a (PKCa), 1:5000, Sigma; GluR1, 1:2000,
Upstate; pGluR1, 1:1000, Millipore; PSD-95, 1:500, Che-
micon; protein interacting with C kinase 1 (PICK1),
1:400, Santa Cruz; GRIP1, 1:1000, Millipore; stargazin,
1:500, Chemicon; AMPA receptor binding protein
(ABP), 1:400, Santa Cruz; KIF3A, 1:1000, Covance; cal-
retinin, 1:2000, Abcam; calbindin, 1:2000, Abcam;
aCaMKII 1:1000, Upstate; bCaMKII: 1:1000, Invitrogen).
Blots were washed three times for 10 min in PBST,
incubated for 2 h in secondary antibodies (IgG-HRP,
Santa Cruz; 1:5000 in 5% NFDM-PBST) followed by
three more washes of 10 min in PBST. Immunostaining
was revealed by the SuperSignal West Dura Extended
Duration Substrate kit (Thermo Scientific, Waltham,
MA, USA), and scanned using the Quantity One ima-
ging system (Bio-Rad). Densitometry for each band was
measured using ImageJ (U.S. National Institutes of
Health, Bethesda, MD, USA). b-actin (1:5000, Sigma)
was used as a loading control.
Immunohistochemistry
Cryosections were washed 2 × 10 min in PBS, then
blocked with blocking buffer for 30 min. Cryosections
were incubated overnight at 4°C in primary antibodies
diluted in blocking buffer (GluR2, 1:500, Chemicon or
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1:200; GRIP1, 1:500; stargazin, 1:500; ABP, 1:100;
KIF3A, 1:500; calbindin, 1:1000). These primary antibo-
dies were from different species in every case and they
did not cross-react on Western Blots. After washing 3 ×
10 min in PBS, sections were incubated for 45 min at
room temperature in secondary antibodies (cy3-, 488-
or 647-conjugated IgG, Invitrogen) diluted 1:1000 in
blocking buffer. For double or triple staining, sections
were sequentially incubated with primary antibodies and
secondary antibodies as above. After incubation with
antibodies, sections were washed 3 × 10 min in PBS,
then treated with 10 μM DAPI (Invitrogen) for 5 min at
room temperature. Sections from all groups were pro-
cessed simultaneously to reduce staining artifacts or
intensity differences. Negative controls were performed
by omission of the primary antibodies.
Confocal imaging
Fluorescent images were acquired with an Olympus
FV1000 laser-scanning confocal microscope (Olympus,
Tokyo, Japan). Settings were chosen so that pixel intensities
for the brightest samples were just below saturation, except
when the processes of retinal neurons had to be clearly
determined, in which case signals from certain areas (soma
of the retinal neurons) were saturated in order to obtain a
clear perimeter of the neurites. Optical slice units were 0.5
μm. Neuritogenesis was analyzed as described [8]. In brief,
neurite length was measured from the point of emergence
at the cell body to the tip of each segment. One section
was selected from each animal, and 20 longest dendrites
from 20 rod bipolar cells in a specific region (ventral mid-
peripheral region, 120 μm in length) were measured and
calculated as the mean. Quantification of the morphologi-
cal parameters was carried out using ImageJ by investiga-
tors blinded to experimental conditions.
Data analysis
Data of neuritogenesis were expressed as mean ± SD
and analyzed with SPSS 12.0 (SPSS Inc.). Statistical
comparisons were made using Bonferroni tests and ana-
lysis of variance (ANOVA), P < 0.05 was defined as the
level of significance. Protein levels represented pooled
data of entire groups and were expressed as means only.
To study the rationality ofp o o l i n gs a m p l e si no u r
experiment, we actually set up 3 batches of animals.
There were 3 mice per group in each batch (i.e. 9 mice
in total for each group). We pooled the 3 mice’sr e t i n a s
from each group in each batch and ran the western
blotting for protein analysis. It was found that the biolo-
gical variations for the 9 mice were low and GluR2
increase, for example, was significant during early LIRD
(Additional file 1 Figure S1).
Additional material
Additional file 1: Figure S1. Rationality of pooling samples in our
experiment.
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